SBI Capital Markets Limited ("Manager to the Offer") has submitted to BSE a copy of Public Announcement for the attention of the Public Shareholders of Bliss GVS Pharma Ltd under Regulation ....
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anupam Rasayan India Limited has announced an open offer to acquire up to 2,77,26,848 equity shares (26% of expanded voting capital) of Bliss GVS Pharma Ltd at ₹299 per share. This offer, worth up to ₹829 crore assuming full acceptance, is triggered by Anupam Rasayan's agreement to purchase 43.30% stake (₹1,369 crore) from existing promoters and certain shareholders including Shruti Vishal Rao, Narsimha Shibroor Kamath, and Gulbarga Trading. After completing both transactions (with full tender acceptance), Anupam Rasayan will hold 69.51% of Bliss GVS Pharma and become the new promoter. The existing promoter group will exit and be reclassified as public shareholders. The offer is not conditional on minimum acceptance and the acquirer has confirmed no delisting plans.
This open offer gives public shareholders a chance to exit at ₹299 per share (cash). The stock may trade near the offer price as the market assesses whether Anupam Rasayan's entry will create value in the pharma company. Shareholders who tender will receive cash; those who don't will remain as public shareholders with reduced stake.